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Abstract	
Invariant	 natural	 killer	 T	 cells	 (iNKT	 cells)	 recognize	 endogenous	 and	 exogenous	 lipid	 antigens	
presented	 in	 the	 context	 of	 CD1d	molecules.	 The	 ability	 of	 iNKT	 cells	 to	 recognize	 endogenous	
antigens	 represents	 a	 distinct	 immune	 recognition	 strategy,	which	 underscores	 the	 constitutive	
memory	phenotype	of	 iNKT	 cells	 and	 their	 activation	during	 inflammatory	 conditions.	However,	
the	mechanisms	regulating	such	‘tonic’	activation	of	iNKT	cells	remain	unclear.	Here	we	show	that	
the	 spatiotemporal	 distribution	 of	 CD1d	 molecules	 on	 the	 surface	 of	 antigen	 presenting	 cells	
(APCs)	modulates	activation	of	iNKT	cells.		By	using	super-resolution	microscopy,	we	demonstrate	
that	 CD1d	 molecules	 form	 nanoclusters	 at	 the	 cell	 surface	 of	 APCs,	 whose	 size	 and	 density	 is	
constrained	by	 the	 actin	 cytoskeleton.	Dual	 color	 single	 particle	 tracking	 revealed	 that	 diffusing	
CD1d	 nanoclusters	 are	 actively	 arrested	 by	 the	 actin	 cytoskeleton	 preventing	 their	 further	
coalescence.	Formation	of	larger	nanoclusters	occurs	in	the	absence	of	interactions	between	CD1d	
cytosolic	 tail	 and	 the	 actin	 cytoskeleton	 and	 correlates	 with	 enhanced	 iNKT	 cell	 activation.	
Importantly,	and	consistently	with	iNKT	cell	activation	during	inflammatory	conditions,	exposure	
of	APCs	to	the	TLR7/8	agonist	R848	increases	nanocluster	density	and	iNKT	cell	activation.	Overall,	
these	results	define	a	novel	mechanism	that	modulates	iNKT	cell	autoreactivity	based	on	the	tight	
control	 by	 the	APC	 cytoskeleton	 of	 the	 sizes	 and	 densities	 of	 endogenous	 antigen	 loaded	 CD1d	
nanoclusters.	
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Significance	Statement	
Invariant	 natural	 killer	 T	 (iNKT)	 cells	 react	 against	 CD1d-antigen	 presenting	 cells	 (APCs)	 in	 the	
absence	of	exogenous	antigens,	a	feature	defined	as	autoreactivity.	How	iNKT	cell	autoreactivity	 is	
fine-tuned	 to	 prevent	 autoimmunity	 remains	 enigmatic.	 Here	 we	 demonstrate	 that	 iNKT	 cell	
activation	 is	 regulated	 by	 the	 lateral	 nanoscale	 organization	 of	 CD1d	 loaded	with	 exogenous	 and	
endogenous	antigens.	Using	a	combination	of	advanced	biophysical	techniques	we	show	that	CD1d	
molecules	organize	 in	nanoclusters	on	 the	membrane	of	APCs.	We	 further	discover	 that	 the	actin	
cytoskeleton	prevents	enhanced	CD1d	nanoclustering	by	hindering	physical	encountering	between	
CD1d	 diffusing	 nanoclusters,	 reducing	 basal	 iNKT	 cell	 activation.	 As	 such,	 regulation	 of	 CD1d	
nanoclustering	 through	 the	 actin	 cytoskeleton	 constitutes	 a	 novel	 mechanism	 to	 fine-tune	
peripheral	iNKT	cell	autoreactivity.	
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\body	
Introduction	
It	is	well	established	that	different	populations	of	T	lymphocytes	can	recognize	not	only	peptides	in	
the	context	of	MHC	class	I	and	class	II	molecules,	but	also	foreign	and	self-lipids	in	association	with	
CD1	proteins(1),	 antigen-presenting	molecules	which	 share	 structural	 similarities	with	MHC-class	 I	
molecules.	Of	the	five	CD1	isoforms,	CD1d	restricts	the	activity	of	a	family	of	cells	known	as	invariant	
Natural	Killer	T	(iNKT)	cells,	because	of	their	semi-invariant	T	Cell	Receptor	(TCR)	usage(1).	To	date,	
the	exogenous	glycolipid	α-GalactosylCeramide	(α-GalCer)	represents	the	best	characterized	CD1d-
restricted	 agonist	 for	 iNKT	 cells(2).	 Unlike	 conventional	 peptide	 specific	 T	 cells,	 iNKT	 cells	 react	
against	 CD1d+	 antigen	 presenting	 cells	 (APCs)	 in	 the	 absence	 of	 exogenous	 antigens,	 a	 feature	
defined	as	autoreactivity(3).	 iNKT	cell	autoreactivity	underpins	the	constitutive	memory	phenotype	
of	iNKT	cells	and	their	ability	to	be	activated	during	a	variety	of	immune	responses,	from	infections	
to	 cancer	 and	 autoimmunity(1).	 Some	 of	 the	 endogenous	 antigens	 known	 to	 elicit	 iNKT	 cell	
autoreactivity	belong	to	glycosphingolipid	families,	with	a	mix	of	α-	and	β-anomeric	configurations	
(4-7).	 How	 iNKT	 cell	 autoreactivity	 is	 fine-tuned	 to	 prevent	 autoimmunity	 is	 subject	 of	 much	
investigation.	Previous	results	have	shown	that	exposure	of	APCs	to	TLR	agonists	enhances	iNKT	cell	
autoreactivity	 (8,	 9),	 consistent	 with	 the	 proposed	 mechanism	 by	 which	 ligand	 availability	 is	
regulated	by	lysosomal	glycosidases	(4,	6).			
The	 recent	 application	 of	 advanced	 optical	 techniques(10-13)	 in	 combination	 with	 substrate	
patterning	 and	 functionalization(14,	 15)	 	 is	 providing	 detailed	 information	 on	 how	 the	 lateral	
organization	 of	 a	 variety	 of	 molecules	 located	 on	 both	 sides	 of	 the	 immunological	 synapse	
contributes	 to	 controlling	 T	 cell	 activation.	 Specifically,	 single	 molecule	 dynamic	 approaches	 and	
super-resolution	 optical	 nanoscopy	 experiments	 have	 provided	 indisputable	 proof	 that	 many	
receptors	 on	 the	 cell	 membrane	 organize	 in	 small	 nanoclusters	 prior	 to	 ligand	 activation(16).	
Membrane	 nanodomains	 enriched	 in	 cholesterol	 and	 sphingolipids(17),	 protein-protein	
interactions(18)	 and	 interactions	 between	 transmembrane	 proteins	 and	 the	 cytoskeleton(19,	 20)	
have	been	all	 implicated	in	regulating	receptor	dynamics	and	nanoclustering.	An	emerging	concept	
attributes	 the	 actin	 cytoskeleton	 the	 ability	 of	 imposing	 barriers	 or	 fences	 on	 the	 cell	membrane	
restricting	the	lateral	mobility	of	transmembrane	proteins	(19-21).	This	transient	restriction	would	in	
turn	 increase	 the	 local	 concentration	 of	 transmembrane	 proteins	 leading	 to	 protein	 nanoclusters.	
For	 instance,	 it	has	been	shown	that	the	actin	cytoskeleton	promotes	the	dimerization	rate	of	EGF	
receptors	and	 facilitates	 ligand	binding	and	signaling	activation	 (18,	22).	Confinement	of	CD36	has	
also	been	observed	as	a	result	of	its	diffusion	along	linear	channels	dependent	on	the	integrity	of	the	
cortical	 cytoskeleton(23).	 This	 constrained	 diffusion	 promotes	 CD36	 clustering,	 influencing	 CD36-
mediated	signaling	and	internalization.	A	similar	mechanism	has	been	proposed	for	the	maintenance	
of	 MHCI	 clusters	 on	 the	 cell	 membrane	 by	 the	 actin	 cytoskeleton,	 with	 loss	 of	 MHCI	 clustering	
resulting	in	a	decreased	CD8-T	Cell	activation(24,	25).		
Recent	 confocal	 microscopy	 studies	 have	 revealed	 that	 the	 association	 between	 agonist	 loaded-
CD1d	molecules	 and	 lipid	 rafts	might	 contribute	 to	 the	 regulation	 of	 iNKT	 cell	 activation(26).	 This	
elegant	 study	 for	 the	 first	 time	 linked	 the	 spatial	 organization	 of	 CD1d	 molecules	 on	 the	 cell	
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membrane	of	APCs	with	the	activation	profile	of	iNKT	cells.	However,	it	remains	unclear	whether	the	
results	 of	 these	 experiments	 obtained	 using	 mouse	 cells	 can	 be	 extended	 to	 human	 cells	 and	
whether	further	insights	can	be	obtained	by	using	higher	resolution	microscopy.	Indeed,	it	is	not	yet	
known	 whether	 surface	 expressed	 CD1d	 molecules	 exist	 as	 monomers	 or	 as	 nanoclusters,	 and	
whether	 the	 actin	 cytoskeleton	might	 regulate	 CD1d	 lateral	 organization	 and	 iNKT	 cell	 activation.	
Interestingly,	it	has	been	recently	reported	that	the	actin	cytoskeleton	impairs	antigen	presentation	
by	CD1d	and	that	disruption	of	F-actin	or	 inhibition	of	the	Rho-associated	protein	kinase	enhances	
CD1d-mediated	antigen	presentation	 (27).	 These	 results	 suggest	 that	 the	actin	 cytoskeleton	might	
regulate,	in	a	not	yet	known	manner,	antigen	presentation	by	CD1d	molecules.	
Here,	 we	 combined	 dual-color	 single	 molecule	 dynamic	 approaches	 with	 super-resolution	 optical	
nanoscopy	 to	characterize	 for	 the	 first	 time	the	spatiotemporal	behavior	of	CD1d	on	 living	human	
myeloid	 cells.	 We	 find	 that	 α-GalCer	 loaded	 human	 CD1d	 (hCD1d)	 molecules	 are	 organized	 in	
nanoclusters	 on	 the	 cell	 membrane	 of	 APCs.	 We	 report	 that	 the	 actin	 cytoskeleton	 prevents	
enhanced	 hCD1d	 nanoclustering	 by	 hindering	 physical	 encountering	 between	 hCD1d	 diffusing	
nanoclusters,	 thus	 reducing	 basal	 iNKT	 cell	 activation.	 Furthermore,	 we	 observed	 an	 increase	 in	
nanocluster	 density	 upon	 activation	 of	 APCs	with	 inflammatory	 stimuli,	 such	 as	 Toll	 like	 receptor	
(TLR)	stimulation,	mirroring	the	increased	iNKT	cell	stimulation.	Notably,	even	during	 inflammation	
the	actin	cytoskeleton	retains	an	important	role	to	limit	hCD1d	cluster	size	and	iNKT	cell	activation.	
Overall,	our	 results	 suggest	 that	 regulation	of	CD1d	nanoclustering	 through	 the	actin	cytoskeleton	
represents	a	novel	mechanism	to	fine	tune	peripheral	iNKT	cell	autoreactivity.	
	
Results	
	
The	actin	cytoskeleton	regulates	the	mobility	of	α -GalCer	loaded	hCD1d	molecules	
To	study	the	lateral	behavior	of	hCD1d	on	the	cell	membrane	of	APCs,	we	first	performed	high-speed	
single	 particle	 tracking	 (SPT)	 on	 the	 human	 myelomonocytic	 cell	 line	 THP-1,	 transduced	 with	
lentiviral	 vectors	 encoding	 hCD1d	 molecules	 and	 pulsed	 with	 the	 iNKT	 cell	 agonist	 α-GalCer.	 α-
GalCer	 loaded	 hCD1d	 molecules	 were	 labeled	 at	 low	 density	 using	 a	 conjugate	 consisting	 of	 a	
biotinylated	 iNKT-	 T	 cell	 receptor	 (iNKT-TCR)	 (9,	 28)	 and	 a	 streptavidin	 (SAV)	 coated	quantum	dot	
(QD655)	(Fig.	1A).	To	ensure	a	single	iNKT-TCR	per	QD,	the	iNKT-TCR-QD	conjugate	was	prepared	in	
an	excess	of	 free	biotin	 to	occlude	SAV-QD	excess	binding	sites.	As	 further	control	 to	 rule	out	any	
potential	 cross-linking	 effects	 induced	 by	 the	 SAV-QD	 multivalency,	 we	 also	 used	 the	 α-GalCer-
hCD1d	specific	Fab	fragment	(Fab9b)(9,	28,	29)	covalently	attached	to	the	small	dye	Atto647N.		As	a	
third	 control	 for	 the	 iNKT-TCR	 probe,	 α-GalCer	 loaded	 hCD1d	 molecules	 were	 labeled	 using	 a	
monovalent	 anti-CD1d	 antibody	 (CD1d42)	 conjugated	 to	 a	 QD	 under	 excess	 of	 free	 biotin.	 THP-1	
cells	 were	 imaged	 on	 the	 ventral	 side	 using	 total	 internal	 reflection	 fluorescence	 microscopy	
(TIRFM).	 Individual	 features	were	detected	and	 tracked	 to	 generate	mobility	 trajectories	 (Fig.	 1B).	
Individual	 trajectories	were	analyzed	by	deriving	 their	 instantaneous	diffusion	coefficients	at	 short	
diffusion	 times	 (time	 lags	 2	 to	 4,	 i.e.,	 20ms)	 D2-4	 (Fig.	 1C-F).	 The	 median	 D2-4	 from	 multiple	
trajectories	 of	 α-GalCer	 loaded	 hCD1d	 molecules	 labeled	 with	 the	 iNKT-TCR-QD	 conjugate	 on	
different	cells	was	0.029	µm2/s	(Fig.	1C).	Similar	diffusion	profiles	and	median	diffusion	coefficients	
were	 obtained	with	 Fab9b-Atto647N	 (Fig.	 1C)	 or	when	 labeling	α-GalCer	 loaded	 hCD1d	 using	 the	
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monovalent	 CD1d42-QD	 Ab	 (Fig.	 S1A).	 Altogether,	 these	 controls	 demonstrate	 that	 the	 lateral	
mobility	 of	α-GalCer	 loaded	hCD1d	molecules	 is	 not	 affected	by	 the	 iNKT-TCR-QD	 conjugate	 used	
throughout	this	study.	
To	address	the	potential	role	of	the	actin	cytoskeleton	in	regulating	the	lateral	mobility	of	hCD1d	on	
the	 cell	 membrane	 of	 APCs,	 we	 treated	 THP-1	 cells	 with	 the	 actin	 cytoskeleton-perturbing	 drug	
Cytochalasin	 D	 (CytoD)(20).	 CytoD	 treatment	 resulted	 in	 a	 nearly	 three-fold	 reduction	 in	 the	
instantaneous	mobility	of	α-GalCer	 loaded	hCD1d	with	a	median	D2-4	of	0.011	µm
2/s	(Fig.	1D).	Cell	
viability	was	not	compromised	under	these	conditions,	as	shown	by	propidium	iodide	staining	(Fig.	
S1B).	Similar	results	were	obtained	when	we	followed	the	lateral	mobility	of	α-GalCer	loaded	hCD1d	
molecules	upon	CytoD	treatment	using	the	monovalent	CD1d42-QD	Ab	(Fig.	S1A).		
It	has	previously	been	shown	that	treatment	of	cells	with	a	range	of	cytoskeleton	perturbing	drugs	
increases	 the	 instantaneous	 mobility	 of	 receptors,	 such	 as	 the	 FcɛRI	 receptor(19)	 and	 the	 B-Cell	
receptor(20),	which	has	been	accounted	for	by	the	breaking	of	actin	barriers	that	otherwise	restrict	
the	diffusion	of	receptors	on	the	plasma	membrane.	To	enquire	whether	the	unexpected	observed	
reduced	mobility	of	hCD1d	is	specific	or	whether	it	results	from	an	overall	change	of	the	membrane	
environment	due	to	the	CytoD	treatment,	we	compared	it	with	the	mobility	of	CD71	molecules	on	
THP-1	 cells.	 In	marked	 contrast	 to	 the	 behavior	 of	 hCD1d	 and	 consistent	 with	 the	 literature(30),	
treatment	of	THP1	cells	with	a	similar	concentration	of	CytoD	 led	to	a	significant	 increase	of	CD71	
diffusion	(Fig.	S1C),	indicating	that	the	observed	reduced	mobility	of	hCD1d	is	specific.	Finally,	to	rule	
out	 any	 other	 potential	 secondary	 effects	 induced	 by	 CytoD,	 we	 measured	 the	 mobility	 of	 a	
cytoplasmic	 tail	 deleted	 hCD1d	 (TD-hCD1d)	mutant,	 which	 lacks	 the	 final	 10	 amino	 acid	 residues	
including	 the	 AP-2	 and	 AP-3	 internalization	 motif	 and	 the	 lysine	 residue	 which	 is	 a	 target	 for	
ubiquitination(31).	Similar	to	the	results	obtained	with	CytoD	treated	THP-1	cells,	the	mobility	of	the	
α-GalCer	 loaded	 TD-hCD1d	mutant	 was	 three-fold	 lower	 than	 that	 of	α-GalCer	 loaded	 wild	 type	
(WT)	hCD1d	(Fig.	1D).		
Upon	biosynthesis	and	egress	from	the	ER,	CD1d	molecules	reach	the	cell	surface	and	continuously	
recycle	 through	 the	 endolysosomal	 compartment,	 where	 they	 sample	 different	 pools	 of	 self	 and	
foreign	 lipid	 antigens(32).	 While	 presentation	 of	 complex	 exogenous	 antigens	 requires	 CD1d	
molecules	to	traffic	deep	into	the	lysosomes(33),	autoreactivity	of	human	iNKT	cells	has	been	shown	
to	have	different	 requirements	 for	CD1d	 lysosomal	 trafficking,	possibly	as	a	 result	of	 the	different	
APCs	used	in	the	experiments	(28,	34).	To	test	whether	these	different	trafficking	pathways	have	an	
influence	 on	 the	 lateral	 mobility	 of	 hCD1d,	 we	 imaged	 unpulsed	 THP-1	 cells	 and	 tracked	 hCD1d	
labeled	with	anti-CD1d42-QD	(Fig.	1A).	The	 instantaneous	diffusion	of	control	unpulsed	WT-hCD1d	
molecules	was	approximately	a	factor	of	two	lower	than	α-GalCer	loaded	molecules,	with	a	median	
D2-4	value	of	0.015µm
2/s	(Fig.	1E).	Interestingly,	the	lateral	mobility	of	unpulsed	WT-hCD1d	was	not	
affected	by	CytoD	treatment	(median	D2-4=0.017	µm
2/s),	in	strong	contrast	to	the	mobility	reduction	
observed	 on	 α-GalCer	 loaded	 molecules	 after	 CytoD	 treatment.	 Moreover,	 the	 mobility	 of	 the	
unpulsed	TD-hCD1d	mutant	was	modestly	reduced	by	1.5-fold	as	compared	to	the	WT	counterpart	
(0.009	µm2/s)	(Fig.	1E).	As	such,	these	results	show	that	unpulsed	CD1d	molecules	are	less	sensitive	
to	 disruption	 of	 actin	 cytoskeleton	 interactions.	 Importantly,	 these	 data	 also	 indicate	 that	 the	
mobility	of	hCD1d	differs	depending	on	whether	we	 sample	molecules	 that	have	 just	 reached	 the	
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cell	 surface	 from	the	ER	 (i.e.,	unpulsed	and	thus	presenting	self-lipids)	or	whether	 they	have	been	
recycling	through	the	early	and	late	endosomes.		
To	 further	 strengthen	 these	 observations,	we	 analyzed	 the	 lateral	mobility	 of	WT-hCD1d	 and	 TD-
hCD1d	molecules	loaded	with	Gal(α1->2)GalCer	(hereafter	referred	to	as	Gal-GalCer),	which	requires	
cleavage	of	the	terminal	galactose	by	α-galactosidase	A	in	the	lysosome	for	recognition	by	the	iNKT-
TCR(33).	Recognition	of	this	pool	of	hCD1d	molecules	by	the	iNKT-TCR-QD	thus	identifies	a	cohort	of	
hCD1d	molecules	 that	 has	 exclusively	 trafficked	 through	 the	 endolysosomes	 and	 recycled	 back	 to	
the	cell	 surface.	These	experiments	 indicated	that	 the	 lateral	mobility	of	Gal-GalCer	 loaded	hCD1d	
molecules	was	significantly	reduced	upon	CytoD	treatment	or	deletion	of	the	cytosolic	tail	(Fig.	1F),	
in	analogy	to	the	results	obtained	for	α-GalCer	loaded	hCD1d.	Moreover,	we	also	analyzed	individual	
trajectories	 at	 longer	 times	 (over	 250ms)	 to	 obtain	 further	 insight	 on	 the	 mobility	 of	 hCD1d	
molecules.	Consistent	with	the	reduction	in	the	D2-4	values	(instantaneous	diffusion),	the	degree	of	
anomalous	diffusion	at	 longer	observation	times	 increased	for	α-Galcer	and	the	Gal-GalCer	 loaded	
hCD1d	molecules,	 whereas	 no	 changes	were	 observed	 in	 the	 unpulsed	 case	 (Fig.	 S2).	 Altogether,	
these	results	demonstrate	that	in	the	absence	of	interactions	between	the	cytoplasmic	tail	of	hCD1d	
and	 the	 actin	 cytoskeleton,	 the	 lateral	 mobility	 of	 hCD1d	 recycled	 through	 the	 endosomes	 is	
drastically	reduced.	
hCD1d	molecules	 form	 nanoclusters	 on	 the	 surface	 of	 APCs	 whose	 properties	 depend	 on	 actin	
cytoskeleton	interactions.		
Previous	 reports	 indicate	 that	 the	 actin	 cytoskeleton	 regulates	 the	 lateral	 organization	 and	
nanoclustering	 of	 receptors	 on	 the	 cell	 membrane	 (23).	 	 Given	 the	 marked	 effect	 of	 the	 actin	
cytoskeleton	 and	 the	 cytoplasmic	 tail	 of	 hCD1d	 on	 the	 lateral	 mobility	 of	 hCD1d	 molecules	 that	
traffic	 through	 endosomes,	 we	 thought	 to	 visualize	 the	 nanoscale	 organization	 of	 hCD1d	 on	 the	
surface	of	THP-1	 cells	using	 stimulated	emission	depletion	 (STED)	nanoscopy	 (35).	 STED	 images	of	
anti-CD1d42	 labeled	 hCD1d	were	 performed	on	 the	 dorsal	 side	 of	 fixed	 THP-1	 cells.	 To	 avoid	 any	
potential	artifacts	related	to	CytoD	treatment	on	the	dorsal	cell	membrane	morphology	that	could	
affect	 the	quantification	of	STED	 images,	we	particularly	 focused	on	WT-hCD1d	and	the	TD-hCD1d	
mutant	 since	SPT	experiments	 showed	similar	 lateral	diffusion	of	exogenous	 lipid-loaded	 (αGalCer	
and	 GalGalCer)	 TD-CD1d	 molecules	 and	 CytoD	 treated	 samples.	 Images	 were	 analyzed	 using	 a	
custom-made	 algorithm	 based	 on	 Bayesian	 inference	 of	 the	 fluorescence	 intensity	 distribution,	
improving	 data	 quantification	 and	 increasing	 the	 effective	 resolution	 beyond	 that	 of	 STED	 raw	
images	 (see	 Materials	 and	 Methods	 and	 Ref.	 36).	 Interestingly,	 α-GalCer	 loaded	 WT-hCD1d	
molecules	formed	small	nanoclusters	on	the	surface	of	THP-1	cells	with	a	median	cluster	size	of	78	
nm,	containing	3.8	median	number	of	hCD1d	molecules/cluster	(Fig.	2A-C)	resulting	in	a	nanocluster	
density	 of	 around	 75	 hCD1d/µm2	 (Fig.	 2D).	 To	 verify	 that	 CD1d	 nanoclustering	 is	 real	 and	 not	
resulting	from	the	enhanced	expression	of	hCD1d	on	transduced	THP-1	cells,	we	imaged	hCD1d	on	
blood-derived	primary	human	CD14+	monocytes.	Analysis	of	STED	images	confirmed	the	presence	of	
hCD1d	nanoclusters,	albeit	being	smaller	 in	size	(49	nm	as	median	cluster	size)	compared	to	THP-1	
cells	(Fig.	S3).	These	data	demonstrate	that	hCD1d	forms	nanoclusters	on	the	plasma	membrane	of	
APCs.	
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Remarkably,	α-GalCer	loaded	TD-hCD1d	molecules,	lacking	the	cytoplasmic	tail,	showed	significantly	
larger	 and	 denser	 nanoclusters	 with	 a	 molecular	 density	 nearly	 three-fold	 higher	 (197	 ±	 17	
hCD1d/µm2)	than	α-GalCer	loaded	WT-hCD1d	(Fig.	2A-D).	A	similar	trend	was	equally	observed	for	
Gal-GalCer	loaded	TD-hCD1d.	Indeed,	larger	nanoclusters	(median	cluster	size	of	93	nm,	8.2	median	
number	of	hCD1d	molecules/cluster)	and	 increased	density	(187	±	12	hCD1d/µm2)	were	measured	
compared	 to	 their	WT-hCD1d	 counterparts	 (median	 cluster	 size	 of	 80	 nm,	 3.3	median	 number	 of	
hCD1d	molecules/cluster,	 80	 ±	 6	 hCD1d/µm2)	 (Fig.	 2A,E-G).	 These	 results	 show	 that	 the	mobility	
reduction	measured	on	the	exogenous-loaded	TD-CD1d	molecules	(Fig.	1D,F)	is	accompanied	by	an	
increased	 nanoclustering	 on	 the	 cell	 surface.	 In	 contrast,	 self-lipid	 loaded	 TD-hCD1d	 molecules	
displayed	 only	 slightly	 larger	 nanoclusters,	 in	 terms	 of	 size	 and	 number	 of	 molecules	 with	 no	
significant	changes	in	nanocluster	densities	compared	to	self-lipid	loaded	WT-hCD1d	molecules	(Fig.	
2A,H-J).	 These	 small	 changes	 in	 nanoclustering	 degree	 on	 unpulsed	 TD-hCD1d	 compared	 to	WT-
hCD1d	 are	 also	 consistent	with	 the	minor	 changes	 observed	 on	 their	 lateral	mobility.	 Altogether,	
these	 results	 indicate	 once	more	 that	 the	 effect	 of	 the	 cytoplasmic	 tail	 on	 hCD1d	 organization	 is	
predominantly	on	the	pool	of	molecules	that	has	trafficked	through	the	lysosome.		
Perturbation	 of	 the	 actin	 cytoskeleton	 increases	 dynamic	 encounters	 between	α -GalCer	 loaded	
hCD1d	nanoclusters	
We	hypothesized	that	the	 increased	nanoclustering	observed	on	α-GalCer	 loaded	TD-hCD1d	might	
result	 from	dynamic	encounters	between	 individual	nanoclusters	that	could	favorably	 lead	to	 local	
enrichment	of	hCD1d	molecules	in	the	absence	of	cytoskeleton	interactions.	To	test	this	possibility	in	
living	cells	we	applied	dual-color	SPT.	We	labeled	α-GalCer	loaded	hCD1d	using	iNKT	TCRs	coupled	to	
two	 different	 QDs	 (Fig.	 3A)	 at	 equimolar	 concentrations	 to	 increase	 the	 probability	 of	 detecting	
nanocluster	 interaction	 events	 (Fig.	 3B,	 Movies	 S1-S3),	 while	 allowing	 for	 single	 pair	 trajectory	
recording.	Two-dimensional	trajectories	of	spatially	close	QDs	(red	and	green)	were	generated	(Fig.	
3C)	 and	 their	 separation	 distance	 was	 plotted	 vs.	 time	 (Fig.	 3D).	 In	 the	 case	 of	 truly	 interacting	
nanoclusters,	 their	 separation	 distances	 should	 remain	 small	 (close	 to	 the	 nanocluster	 size)	 for	
periods	 longer	 than	random	encounter	events	 (22,	37).	As	expected,	CytoD	treatment	of	α-GalCer	
loaded	WT-hCD1d	and	α-GalCer	loaded	TD-hCD1d	showed	significantly	shorter	separation	distances	
over	 time	compared	to	 the	untreated	pulsed	WT-hCD1d	control	 (Fig.	3B,D,E)	 (median	 interparticle	
distance	of	106	nm	for	CytoD	treated	cells,	130	nm	for	TD-hCD1d	and	284	nm	for	the	control	case).	
These	 results	 were	 further	 validated	 by	 Monte-Carlo	 simulations	 of	 random	 encounters	 while	
accounting	for	the	respective	diffusion	coefficients	in	the	three	different	cases.	The	shorter	distances	
experimentally	obtained	as	compared	to	the	simulations	(Fig.	3E)	confirm	local	enrichment	of	hCD1d	
nanoclusters	upon	perturbation	of	actin	cytoskeleton	interactions,	following	either	CytoD	treatment	
or	 removal	 of	 the	 hCD1d	 cytoplasmic	 tail.	 This	 sustained	 enrichment	 (lasting	 at	 least	 1s	 in	 our	
experiments)	would	effectively	increase	hCD1d	nanoclustering	in	the	absence	of	actin	cytoskeleton	
interactions,	consistent	with	the	super-resolution	data.		
The	actin	cytoskeleton	spatiotemporally	arrests	diffusing	α -GalCer	loaded	hCD1d	nanoclusters	on	
the	cell	membrane	
The	 data	 presented	 so	 far	 indicate	 that	 the	 actin	 cytoskeleton	 somehow	 hinders	 dynamic	
interactions	between	hCD1d	nanoclusters	preventing	their	 further	coalescence	 into	 larger	clusters.	
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To	directly	visualize	how	actin	might	accomplish	such	a	role	we	performed	dual-color	TIRFM	imaging	
of	 hCD1d	and	actin.	 	We	used	hCD1d	 transduced	THP-1	 cells	 expressing	 lifeact-GFP,	 a	 fluorescent	
marker	of	F-actin(38).	We	labeled	individual	α-GalCer	loaded	hCD1d	nanoclusters	with	the	iNKT-TCR-
QD	 conjugate	 and	 followed	 their	 lateral	mobility	with	 respect	 to	 actin,	 as	 previously	 reported	 for	
other	 cell	 membrane	 receptors(19,	 20)	 (Fig.	 4A).	 Individual	 trajectories	 of	 diffusing	 WT-hCD1d	
nanoclusters	 were	 reconnected	 and	 superimposed	 on	 the	 actin	 image	 (Fig.	 4B,C	 and	Movie	 S4).	
Interestingly,	WT-hCD1d	nanoclusters	exhibited	a	highly	restricted	mobility	in	actin-rich	regions	(Fig.	
4B).	 In	 contrast,	WT-hCD1d	mobility	 increased	 in	 actin-poor	 regions	 (Fig.	 4C).	 These	 observations	
were	 substantiated	 by	 calculating	 the	 instantaneous	 mobility	 of	 a	 selected	 sub-population	 of	
individual	trajectories	that	were	found	to	diffuse	inside	and	outside	actin-rich	regions.	Indeed,	WT-
hCD1d	 nanoclusters	 displayed	 a	 remarkably	 slow	 diffusion	 inside	 actin-rich	 regions	 (median	D2-4	=	
0.0074	µm2/s)	 compared	 to	outside	 (median	D2-4	=	0.025	µm
2/s)	 (Fig.	4D),	 revealing	 that	 the	actin	
cytoskeleton	arrests	mobile	α-GalCer	loaded	WT-hCD1d	nanoclusters	once	they	enter	into	actin-rich	
regions.	In	contrast,	a	similar	analysis	on	a	selection	of	α-GalCer	loaded	TD-hCD1d	trajectories	that	
diffused	 outside	 and	 inside	 actin-rich	 regions	 showed	 no	 significant	 difference	 in	 terms	 of	 their	
instantaneous	 diffusion	 (Fig.	 4D),	 consistent	 with	 the	 observations	 that	 the	 mobility	 of	 the	 TD-
mutant	is	not	affected	by	the	presence	of	the	actin	cytoskeleton	(Fig.	1D).		
To	 obtain	 a	more	 robust	 quantification	 of	 the	 data	 we	 generated	 cartography	maps	 of	α-GalCer	
loaded	 WT-hCD1d	 and	 α-GalCer	 loaded	 TD-hCD1d	 superimposed	 on	 actin	 fluorescence	 images.	
These	maps	provide	the	spatial	positions	of	hCD1d	nanoclusters	as	they	dynamically	explore	the	cell	
membrane	 in	 relation	 to	 actin,	 with	 a	 localization	 accuracy	 of	 20nm(37)	 (Fig.	 4E,F).	 Cartography	
maps	of	α-GalCer	 loaded	WT-hCD1d	showed	two	different	features:	a)	more	dispersed	localization	
positions	outside	actin	regions	resulting	from	its	dynamic	exploration	of	the	cell	membrane	and;	b)	
highly	 concentrated	 localization	 positions	 in	 actin-rich	 areas	 consistent	 with	 the	 arrest	 of	 the	
receptor	 in	 these	 regions	 (Fig.	 4E).	 In	 contrast,	 no	 noticeable	 difference	 in	 terms	 of	 localization	
distribution	 with	 respect	 to	 actin	 was	 observed	 for	α-GalCer	 loaded	 TD-hCD1d	 (Fig.	 4F),	 already	
suggesting	 that	 the	 dynamic	 exploration	 of	 α-GalCer	 loaded	 TD-hCD1d	 is	 actin-independent.	 To	
quantify	these	differences	we	applied	a	custom-made	algorithm	that	calculates	the	relative	fraction	
of	hCD1d	 localization	positions	as	a	 function	of	actin	 intensity	 changes	 in	different	 regions,	∆actin		
(Fig.	 S4	 and	Materials	 and	Methods).	 Positive	 values	 of	 ∆actin	 represent	 actin-rich	 regions,	 while	
negative	values	reflect	actin-poor	regions.	∆actin=0	corresponds	to	no	actin	intensity	changes.	Only	
THP-1	 cells	 bearing	 similar	 expression	 levels	 of	 lifeact-GFP	were	 used	 for	 the	 analysis.	WT-hCD1d	
displayed	a	clear	linear	relationship	between	the	number	of	localization	positions	and	the	amount	of	
actin,	with	a	positive	slope	of	0.34	±	0.03,	 indicating	that	higher	number	of	WT-hCD1d	 localization	
positions	directly	correlates	with	higher	values	of	actin	intensity	(Fig.	4G).	This	increased	number	of	
spatial	positions	in	actin-rich	areas	means	that	the	receptor	explores	multiple	times	the	same	region,	
remaining	 spatiotemporally	 confined	by	 actin.	 Together	with	 the	 restricted	mobility	 of	WT-hCD1d	
observed	on	the	actin-rich	regions	(Fig.	4D),	these	results	prove	that	the	actin	cytoskeleton	actively	
arrests	 WT-hCD1d	 nanoclusters	 on	 the	 cell	 membrane,	 preventing	 their	 further	 aggregation.	 In	
marked	contrast,	the	number	of	localizations	positions	for	TD-hCD1d	shows	only	a	weak	dependence	
on	actin	(slope	of	0.07	±	0.08)	(Fig.	4G)	demonstrating	no	preferred	interactions	between	TD-hCD1d	
and	the	actin	cytoskeleton.		
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Perturbation	of	the	actin	cytoskeleton	of	APCs	results	in	enhanced	iNKT	cell	activation	
Given	that	perturbing	actin	cytoskeleton	interactions	resulted	in	enhanced	α-GalCer	 loaded	hCD1d	
nanoclustering	 on	 APCs,	 we	 sought	 to	 address	 the	 consequences	 of	 such	 altered	 spatiotemporal	
organization	 on	 iNKT	 cell	 activation.	 For	 this,	 APCs	 were	 pulsed	 with	 different	 α-GalCer	
concentrations	and	treated	with	CytoD.	APCs	were	then	 fixed	and	 incubated	with	 iNKT	cells.	 IFN-γ	
production	 upon	 iNKT	 cell	 activation	 was	 measured	 by	 ELISA.	 Notably,	 CytoD-treated	 hCD1d-
tranduced	 THP-1	 cells	 (Fig.	 5A)	 and	 CytoD-treated	 immature	 dendritic	 cells	 (Fig.	 5B)	 elicited	
increased	 iNKT	 cell	 activation	 compared	 to	APCs	with	an	 intact	 actin	 cytoskeleton.	Moreover,	 this	
increase	was	more	pronounced	at	low	agonist	concentrations.	The	increase	in	IFN-γ	production	was	
not	due	to	increased	hCD1d	expression	upon	CytoD	treatment	(Fig.	5C).	These	results	thus	show	that	
the	actin	cytoskeleton	of	APCs	regulates	the	degree	of	iNKT	cell	activation.	Interestingly,	these	data	
are	 fully	 in	 line	with	other	reports	where	nanoclustering	of	antigen	presenting	proteins	have	been	
shown	to	enhance	more	effectively	T	cell	activation	at	low	agonist	densities(39).		
The	actin	cytoskeleton	regulates	hCD1d	nanoclustering	under	inflammatory	conditions	
It	has	been	described	that	innate	stimuli,	such	as	TLR	stimulation,	can	trigger	iNKT	cell	activation	in	a	
CD1d-dependent	manner(8,	 9,	 28,	 40).	 To	 test	whether	 perturbation	 of	 the	 actin	 cytoskeleton	 of	
APCs	exposed	to	inflammatory	conditions	also	resulted	in	enhanced	iNKT	cell	activation,	we	treated	
hCD1d	transduced	THP-1	cells	with	the	TLR7/8	ligand	R848.	After	CytoD	treatment	and	fixation,	APCs	
were	 incubated	 with	 iNKT	 cells.	 Increased	 IFN-γ production	 by	 R848-matured	 CytoD	 treated	WT-
hCD1d	THP1	cells	was	observed,	 in	 line	with	the	results	with	 lipid	pulsed	cells	 (Fig.	5D).	Moreover,	
increased	 IFN-γ production	was	hCD1d-dependent	 since	blocking	with	an	anti-CD1d	Ab	 resulted	 in	
total	 abrogation	 of	 iNKT	 cell	 activation.	 Altogether	 these	 results	 strongly	 indicate	 that	 the	 actin	
cytoskeleton	of	APCs	controls	the	activation	of	iNKT	cells	under	innate	and	adaptive	stimuli.		
Since	perturbation	of	the	actin	cytoskeleton	of	APCs	resulted	in	enhanced	iNKT	cell	activation	upon	
R848	 treatment	 of	 THP1	 cells,	 we	 next	 addressed	 whether	 the	 interaction	 between	 the	 actin	
cytoskeleton	and	the	cytoplasmic	tail	of	hCD1d	regulates	hCD1d	nanoclustering	under	inflammatory	
conditions	as	we	have	shown	for	α-GalCer	 loaded	hCD1d.	We	stimulated	both	WT-hCD1d	and	TD-
hCD1d	 transduced	 cells	 with	 the	 TLR7/8	 ligand	 R848,	 performed	 STED	 nanoscopy	 (Fig.	 6A)	 and	
analyzed	 hCD1d	 cluster	 size	 and	 composition.	 Interestingly,	 R848	 stimulated	 WT-hCD1d	 formed	
smaller	nanoclusters	(47	nm	as	median	cluster	size)	(Fig.	6B)	than	the	unstimulated	controls	(77	nm	
as	 median	 cluster	 size).	 Moreover,	 those	 nanoclusters	 displayed	 a	 significantly	 higher	 number	 of	
hCD1d	molecules	(3.9	compared	to	2.9	median	number	of	unstimulated	hCD1d	molecules)	(Fig.	6C)	
resulting	 in	a	strong	 increase	of	nanocluster	density	 (180	±	20	compared	to	80	±	5	hCD1d/µm2)	of	
WT-hCD1d	 molecules	 under	 inflammatory	 conditions	 (Fig.	 6D).	 Moreover,	 R848	 stimulated	 TD-
hCD1d	nanoclusters	had	a	 larger	size	(90	nm	compared	to	47	nm)	(Fig.	6E)	and	contained	a	higher	
number	 of	 molecules	 (8.1	 compared	 to	 3.9	 hCD1d	molecules)	 (Fig.	 6F)	 than	 the	WT	 counterpart	
resulting	 in	 an	 increased	 nanocluster	 density	 of	 TD-hCD1d	 (231	 ±	 15	 compared	 to	 180	 ±	 20	
hCD1d/µm2)	(Fig.	6G),	in	analogy	with	the	results	obtained	with	α-GalCer-TD-hCD1d	(Fig.	2E,F,G).		
These	results	highlight	the	important	role	of	actin	cytoskeleton	interactions	in	controlling	the	extent	
of	hCD1d	nanoclustering	on	the	cell	membrane	of	APCs	during	inflammatory	conditions.	Moreover,	
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since	hCD1d	undergoes	lysosomal	trafficking	under	inflammatory	conditions	in	analogy	to	α-GalCer	
pulsing(28),	 these	 data	 provide	 further	 support	 for	 the	 role	 of	 the	 interaction	 between	 the	
cytoplasmic	 tail	 of	 hCD1d	 and	 the	 actin	 cytoskeleton	 in	 modulating	 hCD1d	 nanoclustering	 after	
endosome	recycling.		
Discussion	
We	have	 for	 the	 first	 time	 characterized	 the	 spatiotemporal	 behavior	 of	 hCD1d	on	 the	 surface	of	
APCs	at	the	nanoscale	level.	We	found	that	hCD1d	molecules	organize	in	small	nanoclusters	on	the	
cell	membrane.	Moreover,	we	observed	that	the	actin	cytoskeleton	plays	a	major	role	in	regulating	
the	degree	of	hCD1d	nanoclustering	by	segregating	them	away	from	each	other.	Treatment	of	THP-1	
cells	 with	 CytoD	 or	 deletion	 of	 the	 hCD1d	 cytoplasmic	 tail	 led	 to	 larger	 nanoclusters	 and	 a	
concomitant	 reduction	 of	 hCD1d	 mobility.	 Furthermore,	 increased	 hCD1d	 nanoclustering	 directly	
correlated	 with	 enhanced	 iNKT	 cell	 activation.	 Notably,	 under	 inflammatory	 conditions	 hCD1d	
formed	denser	nanoclusters,	whose	organization	also	depended	on	the	actin	cytoskeleton.	This	is	in	
remarkable	analogy	to	the	spatial	organization	of	α-GalCer	and	Gal-GalCer	loaded	hCD1d	molecules	
in	THP-1	cells	either	treated	with	CytoD	or	expressing	tail	deleted	hCD1d	molecules.	Altogether	our	
results	 reveal	 a	 novel	 mechanism	 by	 which	 APCs	 regulate	 iNKT	 cell	 activation	 by	 fine-tuning	 the	
spatial	organization	of	hCD1d	on	the	cell	membrane.			
CD1d	molecules	are	structurally	related	to	the	classical	MHC-I	complex(41).	Using	super-resolution	
near-field	 microscopy,	 clusters	 of	 MHC-I	 from	 70-600	 nm	 in	 size	 were	 observed	 on	 the	 plasma	
membrane	 of	 fibroblasts(42).	 More	 recently,	 it	 was	 shown	 that	 such	 nanoclustering	 strongly	
depends	 on	 the	 actin	 cytoskeleton,	 which	 acts	 as	 a	 barrier	 to	 spatially	 concentrate	 MHC-I	
molecules(24).	 Consistent	 with	 these	 observations,	 deletion	 of	 the	 cytoplasmic	 tail	 increased	 the	
lateral	mobility	of	MHC-I(43).	Clustering	of	MHC-II	complexes	on	the	plasma	membrane	of	APCs	has	
also	been	reported(44-46).	Using	SPT	approaches,	 it	was	shown	that	MHC-II	displays	hop-diffusion	
on	the	cell	membrane	in	a	manner	that	it	is	dependent	on	the	integrity	of	the	actin	cytoskeleton(47).	
Disruption	of	actin	cytoskeleton	interactions	by	either	perturbing	the	actin	network	or	by	truncating	
the	 MHC-II	 cytoplasmic	 tail	 increased	 the	 mobility	 of	 MHC-II	 (47,	 48).	 In	 these	 experiments,	 the	
lateral	 organization	 of	MHC	molecules	 also	 had	 an	 impact	 on	 the	 extent	 of	 T	 cell	 activation,	with	
larger	 clusters	 enhancing	 peptide-specific	 T	 cell	 effector	 functions,	 particularly	 at	 low	 antigen	
density(39).	Notably,	 the	role	of	actin	on	the	spatiotemporal	organization	of	MHC-I	and	MHC-II	on	
the	 cell	 membrane	 of	 APCs	 is	 markedly	 different	 from	 the	 results	 reported	 here	 for	 hCD1d	
molecules.	While	the	actin	cytoskeleton	is	essential	to	actively	maintain	the	clustering	of	MHC-I	and	
MHC-II,	 in	 the	 case	of	hCD1d	molecules	perturbation	of	 the	actin	 cytoskeleton	 leads	 to	enhanced	
aggregation	of	hCD1d	molecules.	Consistent	with	these	findings,	and	also	in	contrast	to	MHC-I	and	
MHC-II,	 disruption	 of	 the	 actin	 cytoskeleton	 or	 deletion	 of	 the	 hCD1d	 cytoplasmic	 tail	 results	 in	
reduced	mobility	of	hCD1d	nanoclusters.	Altogether	our	results	 indicate	that	hCD1d-mediated	lipid	
antigen	 presentation	 is	 differently	 regulated	 at	 the	 cell	 surface	 of	 APCs	 as	 compared	 to	 MHC-
restricted	 peptide	 presentation.	 We	 speculate	 that	 the	 contrasting	 role	 played	 by	 the	 actin	
cytoskeleton	 in	 regulating	 MHC	 and	 hCD1d	 nanoclustering	 reflects	 an	 important	 functional	
difference	between	conventional	peptide-specific	T	cells	and	innate-like	lipid	specific	T	cells.	Indeed,	
whereas	peptide-specific	MHC-I	and	MHC-II	restricted	T	cells	undergo	extensive	negative	selection	in	
the	 thymus(49)	 to	 eliminate	 the	 autoreactive	 peptide	 repertoire,	 peripheral	 iNKT	 cells	 retain	 the	
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ability	 to	 react	 to	 self-lipids	 presented	 by	 CD1d	 molecules.	 This	 so-called	 “autoreactivity	 by	
design”(3)	underpins	the	essential	immunoregulatory	role	of	iNKT	cells.		
Much	 research	 is	being	undertaken	 to	understand	how	 iNKT	cell	 autoreactivity	 in	 the	periphery	 is	
fine-tuned	to	prevent	overt	autoimmunity.	Initial	results	suggested	that	β-anomeric	self-lipids	were	
the	main	self-ligands	recognized	by	the	 iNKT	cell	autoreactive	response(4),	and	that	a	combination	
of	increased	lipid	biosynthesis,	increased	CD1d	expression	and	co-stimulatory	cytokines	was	driving	
iNKT	 cell	 reactivity	 following	 APC	 activation(4,	 8,	 9).	 Co-stimulation	 by	 inflammatory	 cytokines	 is	
essential	to	achieve	iNKT	cell	activation	in	these	infectious	settings,	as	extensive	structural	analysis	
revealed	that	the	iNKT	TCR	interact	with	β-anomeric	self-lipids	CD1d	complexes	with	low	affinity(50).	
Recently,	 evidence	 has	 emerged	 for	 recognition	 of	 α-anomeric	 self-lipids	 bound	 to	 CD1d	
molecules(5,	 6).	 As	 the	 affinity	 of	 the	 iNKT	 TCR	 for	α-anomeric	 lipids	 is	much	 higher	 than	 for	β-
anomeric	 CD1d-lipid	 complexes(50),	 an	 even	 tighter	 regulation	 of	 the	 availability	 of	 α-anomeric	
CD1d-lipid	complexes	is	required.	This	is	accomplished,	for	example,	through	the	concerted	action	of	
biosynthetic	 and	 catabolic	 pathways,	 which	 in	 turn	 are	 modulated	 during	 inflammation(6).	 In	
addition	 to	 the	 affinity	 and	 CD1d	 occupancy	 of	 self-lipid	 antigens,	 our	 results	 underscore	 the	
importance	of	hCD1d	clustering	at	the	cell	surface	of	APCs	as	a	further	mechanism	to	fine	tune	iNKT	
cell	 autoreactivity	 in	 peripheral	 tissues.	 Indeed,	 while	 at	 steady	 state	 the	 actin	 network	 plays	 an	
important	role	in	limiting	basal	iNKT	cell	autoreactivity,	the	observed	increase	in	hCD1d	nanocluster	
density	 upon	 TLR	 stimulation	 suggests	 that	 the	 actin	 cytoskeleton	 might	 also	 regulate	 iNKT	 cell	
activation	 under	 inflammatory	 conditions,	 increasing	 the	 overall	 avidity	 of	 self-lipid	 loaded	 CD1d	
nanoclusters.	 This	hypothesis	 is	 consistent	with	 the	previously	 reported	 increased	 staining	of	 TLR-
matured	APCs	with	a	soluble	iNKT	TCR	detecting	self-lipid	CD1d	complexes(9).	
Endogenous	lipid	loaded	CD1d	molecules	traffic	from	the	ER	to	the	cell	surface	via	the	Golgi	system,	
where	 they	 acquire	 a	 variety	 of	 self-lipids(51).	 From	 the	 plasma	 membrane,	 CD1d	 molecules	
constitutively	 recycle	 through	 the	 endolysosomal	 compartment.	 A	 tyrosine	 based	 internalization	
motif	 in	 the	 cytoplasmic	 tail	 initiates	 clathrin	 dependent	 endocytosis,	 while	 association	 with	 the	
adaptor	AP-2	and	the	Arf-like	GTPase	Arl8b	control	lysosomal	trafficking(52).	It	has	been	previously	
reported	 that	 the	 association	 of	 exogenous	 lipid	 loaded	 CD1d	 with	 membrane	 lipid	 rafts	 on	 the	
plasma	membrane	of	murine	cells	was	dependent	on	the	internal	trafficking	of	CD1d	molecules(26).	
Furthermore,	 it	 has	 also	 been	 shown	 that	 upon	 inflammatory	 stimuli,	 loading	 of	 self-lipids	 also	
requires	 trafficking	 of	 CD1d	molecules	 through	 the	 lysosomal	 compartment(28).	 Our	 data	 extend	
these	 observations	 by	 demonstrating	 that	 regulation	 of	 hCD1d	 nanoclustering	 by	 the	 actin	
cytoskeleton	selectively	differs	between	hCD1d	molecules	presenting	either	exogenous	 lipids,	such	
as	 α-GalCer	 and	 Gal-GalCer,	 or	 self-lipids	 under	 inflammatory	 conditions,	 and	 hCD1d	 molecules	
loaded	with	endogenous	lipids	hCD1d	under	resting	conditions.	These	results	are	consistent	with	the	
hypothesis	that	regulation	of	hCD1d	nanoclustering	by	the	actin	cytoskeleton	selectively	occurs	on	
the	 pool	 of	 recycling	 hCD1d	 molecules	 that	 has	 trafficked	 backward	 and	 forward	 from	 the	
endolysosomal	compartments	to	the	cell	surface,	rather	than	on	the	pool	of	hCD1d	reaching	the	cell	
surface	 directly	 from	 the	 endoplasmic	 reticulum.	 It	 will	 be	 of	 interest	 to	 investigate	 how	 the	
spatiotemporal	behavior	of	hCD1d	might	also	be	affected	by	the	absence	of	lysosomal	lipid	transfer	
proteins	 such	 as	 saposins,	 which	 have	 been	 shown	 to	 facilitate	 exogenous	 as	 well	 as	 self-lipid	
antigen	presentation(28,	53).		
	 14	
The	general	consensus	on	the	emerging	role	of	the	actin	cytoskeleton	in	regulating	cell	membrane	
organization	is	that	it	restricts	the	lateral	diffusion	of	transmembrane	proteins	by	creating	temporal	
physical	barriers	close	to	the	cell	membrane(19).	These	barriers	locally	confine	membrane	receptors	
increasing	 their	 local	concentration	and	promoting	clustering(23).	 In	 the	case	of	hCD1d	molecules,	
we	 observed	 similar	 arrest	 on	 its	 mobility	 in	 actin-rich	 regions.	 However,	 although	 hCD1d	
nanoclustering	might	be	locally	enhanced	on	certain	hotspots	of	the	cell	membrane	by	actin,	 long-
range	 hCD1d	 clustering	 is	 prevented	 by	 lowering	 the	 encountering	 probability	 of	 distant	 diffusing	
hCD1d	nanoclusters.	Thus,	the	actin	cytoskeleton	would	effectively	impose	barriers	and/or	obstacles	
to	the	encountering	of	CD1d	nanoclusters	limiting	their	aggregation	state.	Removal	of	these	fences	
by	 actin	 disruption	 would	 then	 favor	 the	 encountering	 of	 CD1d	 nanoclusters	 leading	 to	 larger	
clusters	(Fig.	7).	In	support	of	this	model	we	have	performed	super-resolution	STORM	imaging	of	the	
actin	cytoskeleton	on	THP-1	cells	before	and	after	CytoD	treatment	(Fig.	S5).	While	the	intact	actin	
cytoskeleton	 shows	 very	 fine	 structures	with	networks	 of	 tiny	 filaments	 and	 small	 compartments,	
treatment	with	CytoD	led	to	a	reduction	of	filament	density	and	caused	the	formation	of	major	actin	
aggregates	separated	by	larger	free	spaces.		
These	 results	 might	 bring	 new	 insights	 on	 how	 the	 actin	 cytoskeleton	 fine-regulates	 the	 lateral	
behavior	of	membrane	proteins	at	multiple	temporal	and	spatial	scales.	Recent	results	have	shown	
the	importance	of	ERM	proteins	 in	linking	the	transmembrane	region	of	surface	receptors,	such	as	
the	BCR,	 to	 the	 actin	 cytoskeleton(20).	 Further	 experiments	 are	warranted	 to	 assess	whether	 this	
family	of	proteins	is	also	controlling	the	interaction	between	the	CD1d	cytosolic	tail	and	the	cortical	
actin	 cytoskeleton.	 Consistent	 with	 this	 possibility,	 it	 has	 recently	 been	 shown	 that	 Rho	 kinase	
controls	antigen	presentation	by	CD1d	molecules	by	prohibiting	actin	fiber	de-polymerization(27).		
In	 conclusion,	 our	 results	 highlight	 a	 novel	mechanism	 that	APCs	 employ	 to	 regulate	 lipid	 antigen	
presentation	 via	 CD1d	molecules	 in	 order	 to	modulate	 iNKT	 cell	 autoreactivity,	 a	 unique	property	
that	distinguishes	 this	 cell	 subset	 from	conventional	CD4+and	CD8+	 T	 cells.	 The	observation	 that	 a	
similar	actin-dependent	mechanism	regulates	presentation	of	exogenous	lipids	and	self-lipids	upon	
inflammatory	stimuli	further	adds	to	the	uniqueness	of	the	CD1d-iNKT	cell	system	in	bridging	innate	
and	 adaptive	 immune	 responses.	 Moreover,	 this	 study	 underscores	 the	 importance	 of	 emerging	
concepts	such	as	protein	nanoclustering	in	deepening	our	understanding	of	how	leukocytes	can	fine-
tune	at	the	molecular	level	the	outcome	of	an	immune	reaction.	We	predict	this	type	of	studies	will	
provide	 essential	 information	 for	 the	 future	 optimization	 of	 novel	 immune-based	 therapeutic	
strategies.	
	
Materials	and	Methods	
Antibodies	 and	 Reagents.	Monoclonal	mouse	anti-human	CD1d	 (CD1d42)	 and	monoclonal	mouse	
anti-human	 CD71	 (clone	 M-A712)	 antibodies	 were	 purchased	 from	 BD	 Pharmingen.	 Poly-L-lysine	
(PLL),	Cytochalasin	D	(CytoD),	DMSO,	Atto647N-NHS	ester	and	di-thiothreithol	(DTT)	were	purchased	
from	Sigma	Aldrich.	Human	fibronectin	(FN)	was	purchased	from	Roche.	Streptavidin	coated	QD655	
and	QD585,	goat-anti-mouse	Alexa	Fluor	488	antibody	(A-11001)	and	D-biotin	were	purchased	from	
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Invitrogen.	 Maleimide-PEG2-Biotin	 and	 Slide-A-Lyzer	 MINI	 Dialysis	 Units	 were	 purchased	 from	
Thermo	Scientific.	
Cell	Medium	 and	 specific	 reagents.	 The	 complete	medium	 (CM)	 used	 throughout	 this	 study	was	
RPMI	1640	(Gibco)	for	THP-1	and	IMDM	(Gibco)	for	iNKT	cells.		CM	was	supplemented	with	2	mM	L-
glutamine,	1%	non-essential	amino	acids,	1%	sodium	pyruvate,	1%	pen/strep,	5	x10-5	2ME	(all	from	
Gibco)	 and	 serum:	 10%	 FCS	 (Sigma)	 for	 THP-1;	 5%	 Human	 AB	 Serum	 (Sigma)	 for	 iNKT	 cells.	
Recombinant	human	IL-2	was	produced	in	our	laboratory	as	described(9).		
Lipids: α-GalCer and Gal(α1→2)GalCer were	 synthesized	 using	 strategies	 described	 previously(9)	
and	 their	 structures	were	 confirmed	 by	mass	 spectrometry.	 The	 dried	 lipids	were	 dissolved	 at	 10	
mg/ml	 in	a	solution	of	chloroform:methanol:water	(10:10:3;	v/v/v),	followed	by	dilution	in	150mM	
NaCl,	 0.5%	Tween	20	 (vehicle	 solution)	 at	 100-200	µg/ml	 stock	 solution	 (depending	on	 solubility).	
The	solution	was	heated	at	80oC	for	5	minutes	followed	by	sonication	for	5	minutes	in	an	ultrasonic	
water	bath.	
Soluble	iNKT-TCR	heterodimers	were	generated	as	described(9).	
Generation	 of	 iNKT	 cells	 and	 Dendritic	 Cells.	 Blood	 was	 purchased	 from	 the	 UK	 National	 Blood	
Service.	Human	iNKT	cells	were	isolated	by	cell	sorting	with	CD1d-α-GalCer	tetramers	and/or	Vα24 
and Vβ11 antibodies	 (Immunotech,	Marseille,	France)	directly	 from	PBMC	or	after	expansion	with	
autologous	DCs	pulsed	with α-GalCer	as	described(28).	iNKT	cells	were	grown	in	CM	(containing	5%	
human	AB	serum	instead	of	FCS)	supplemented	with	1000	U/ml	IL-2	and	periodically	re-stimulated.	
Dendritic	Cells	 (DCs)	were	differentiated	 from	MACS-purified	CD14	monocytes	 from	healthy	blood	
donors	as	described(9).	
Generation	 of	 THP-1	 cells	 over-expressing	 human	 CD1d	 constructs.	 Full	 length	human	CD1d	was	
cloned	in	the	pHR-SIN	lentiviral	vector.	Lentivirus	particles	were	made	as	described(28)	and	used	to	
infect	THP-1	cells	 (ATCC).	Tail	deleted	 (TD)	human	CD1d,	 lacking	 the	 last	10	AA,	was	cloned	 in	 the	
pHR-SIN	lentiviral	vector	using	a	strategy	previously	described(28).	THP1-CD1d	cells	were	transduced	
with	a	lentivirus	encoding	lifeact	GFP	as	previously	described(9).	GFP	positive	cells	were	enriched	by	
cell	sorting.		
iNKT	cell	stimulation	assays.	imDCs	and	THP-1-CD1d	cells	were	plated	at	50000/well	in	U	bottom	96	
well	plates	and	pulsed	overnight	at	the	indicated	concentration	of	lipids.	In	some	experiments,	cells	
were	 matured	 for	 36	 hours	 with	 the	 TLR7/8	 ligand	 R848	 (Invivogen,	 5-10 µg/ml).	 Cells	 were	
extensively	 washed,	 treated	 for	 1	 hour	 at	 37ºC	 with	 CytoD	 used	 at	 10µM	 in	 HBSS	 (Gibco)	 and	
immediately	 fixed	 in	 glutaraldehyde(9).	 Fixed	 APCs	 were	 used	 to	 stimulate	 iNKT	 cells	 (20000-
30000/well	 in	 duplicate	 or	 triplicate).	 iNKT	 cell	 activation	 was	 assessed	 by	 IFN-γ ELISA	 (BD	
Pharmingen)	 on	 supernatants	 harvested	 after	 36	 hours.	 When	 indicated,	 blocking	 anti	 CD1d	
antibody	 (clone	 42.1,	 BD	 Pharmingen)	 was	 added	 at	 20µg/ml	 30	 min	 before	 adding	 iNKT	 cells.	
Viability	of	APCs	and	hCD1d	expression	after	CytoD	treatment	was	assessed	by	Flow	cytometry	upon	
staining	 with	 anti	 CD1d	 PE	 (BD	 Pharmingen)	 and	 propidium	 iodide	 (BD	 Pharmingen).	 Data	 were	
acquired	on	a	Cyan	DAKO	flow	cytometer	and	analyzed	with	Flowjo.	
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Labeling	conjugates	for	SPT	experiments	in	living	cells.	Monovalent	anti-human	CD1d	or	CD71	Abs	
were	 prepared	 from	 CD1d42	 and	 CD71	 Ab	 by	 reduction	 with	 dithiothreitol	 (DTT)	 following	
manufacturer’s	 instructions.	Reduced	Abs	were	 then	biotinylated	with	Maleimide-PEG2-Biotin	and	
quenched	 with	 Iodoacetamide.	 Unbound	 biotin	 was	 removed	 by	 overnight	 dialysis	 at	 4ºC	 using	
Slide-A-Lyzer	 MINI	 Dialysis	 Units.	 To	 monitor	 each	 reaction	 step,	 a	 4-12%	 Bis-Tris	 gel	 under	
denaturing	and	non-denaturing	conditions	was	performed.	
Biotinylated	iNKT-TCR	or	monovalent	Abs	were	mixed	with	streptavidine	coated	QD655	or	QD585	in	
equimolar	concentrations	and	stirred	for	at	 least	2h	at	4ºC.	Excess	of	free	biotin	was	added	to	the	
solution	 to	ensure	a	 single	 iNKT-TCR	 (x10	excess	biotin)	 or	monovalent	Ab	 (x50	excess	biotin)	 per	
quantum	dot.	
Atto647N-NHS	 Ester	 labeling	 of	 the	 Fab9b	 (9,	 29)	 	 was	 performed	 following	 manufacturer’s	
instructions.	
Single	Particle	Tracking.	hCD1d	transduced	THP-1	cells	were	pulsed	overnight	with	50	ng/ml	of	α-
GalCer	or	400	ng/ml	of	Gal-GalCer.	After	30	min	of	incubation	on	FN-coated	coverslips	at	37ºC	and	
5%	 CO2,	 cells	 were	 labeled	 with	 2nM	 of	 the	 iNKT-TCR-QD655	 conjugate	 for	 5	 min	 at	 room	
temperature.	Cells	were	then	washed	with	cell	medium	three	times	to	remove	unbound	iNKT-TCR-
QD655	 conjugates.	 When	 labeling	 the	 cells	 with	 antibody-derived	 probes,	 2%	 human	 serum	
incubation	was	performed	for	5	min	at	room	temperature	before	adding	monovalent	antibodies	or	
Fab	 fragments.	 Monovalent	 CD1d42-QD655	 labeling	 was	 done	 at	 0.2nM	 concentration.	 Fab9b-
Atto647N	 labeling	was	done	at	10nM	concentration.	On	CytoD	treated	samples,	 treatment	 (10µM	
CytoD	 for	 1	 hour)	 was	 performed	 before	 labeling,	 on	 cells	 seeded	 on	 FN-coated	 coverslips	 for	
unpulsed	 hCD1d-THP-1	 cells	 or	 after	 overnight	 pulsing	 with	 α-GalCer	 or	 Gal-GalCer.	 CytoD	 was	
maintained	in	the	medium	while	imaging.	CytoD	controls	were	performed	with	DMSO	diluted	in	the	
imaging	medium	with	the	same	dilution	used	for	CytoD	experiments.	
Fluorescence	 imaging	 was	 performed	 on	 the	 ventral	 side	 of	 the	 cell	 using	 a	 home-made	 single	
molecule	sensitive	microscope	working	under	TIRF	geometry.	Continuous	excitation	of	the	QDs	was	
provided	by	the	488-nm	line	of	an	Ar+	laser	(0.3kW/cm2).	Fluorescence	was	collected	with	a	1.4	NA	
oil	 immersion	objective	(Olympus)	and	guided	 into	an	EM-CCD	camera	(Hamamatsu)	after	suitable	
filtering.	 Movies	 were	 recorded	 at	 a	 frame	 rate	 of	 100Hz	 for	 single	 QDs	 and	 10Hz	 for	 Fab9b-
Atto647N.	For	simultaneous	dual-color	measurements,	the	fluorescence	emitted	light	was	split	and	
selected	 with	 appropriate	 dichroic	 mirror	 and	 filters	 and	 collected	 by	 the	 same	 EM-CCD	 camera	
(dual-color	hCD1d	 imaging)	or	by	a	second	 intensified	CCD	Pentamax	camera	(dual-color	hCD1d	vs	
Lifeact-GFP	 imaging).	 Images	 of	 multi-fluorophore	 fluorescent	 beads	 (0.2	 µm	 Tetraspeck,	
Invitrogen),	 having	 emission	 spectrum	 covering	 the	 two	 spectral	 windows	 were	 obtained	 to	
determine	 the	 spatial	 transformation	 leading	 to	 the	 overlay	 of	 the	 two	 spectral	 channels.	 To	
calculate	 the	 spatial	 transformation,	at	 least	10	beads	appearing	on	both	channels	were	manually	
selected,	 their	 centroid	 positions	 calculated	 with	 subpixel	 accuracy	 and	 stored	 in	 two	 coordinate	
lists.	 The	 transformation	 matrix	 was	 inferred	 from	 the	 coordinate	 lists	 according	 to	 an	 affine	
transformation,	 correcting	 for	 displacement	 and	 small	 chromatic	 aberrations.	 For	 dual-color	
measurements	of	hCd1d,	cells	were	labeled	with	an	equimolar	2nM	concentration	of	2	conjugates:	
iNKT-TCR-QD655	and	iNKT-TCR-QD585.	Simultaneous	dual-color	images	of	QDs	were	performed	at	a	
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frame	rate	of	30Hz.	Dual-color	images	of	Lifeact-GFP	and	iNKT-TCR-QD655	were	obtained	on	double	
transduced	Lifeact-GFP	&	WT-hCD1d	or	TD-hCD1d	THP-1	cells	that	had	been	pulsed	overnight	with	
50	 ng/ml	 of	 α-GalCer.	 Images	 were	 acquired	 at	 a	 frame	 rate	 of	 60Hz.	 Under	 these	 imaging	
conditions,	 no	 changes	 in	 the	 actin	 cytoskeleton	 were	 observed	 and	 the	 actin	 intensity	 signal	
remained	 constant	 during	 the	 time	 of	 the	 experiments.	 Physiological	 conditions	were	maintained	
during	 the	 experiments	 using	 a	 temperature-controlled	 microincubation	 chamber	 (Warner	
Instruments)	in	combination	with	a	constant	5%	CO2	supply	(Okolab).	
Single	particle	 trajectory	analysis.	Trajectories	of	 individual	quantum	dots	with	at	 least	100	points	
were	 reconnected	 with	 Matlab	 routines	 based	 on	 an	 algorithm	 described	 by	 Serge	 et	 al.(54)	
Trajectories	 of	 individual	 Fab9b-Atto647N	were	manually	 reconnected	with	 a	minimum	 trajectory	
length	of	19	points.		
Individual	 trajectories	 were	 analyzed	 by	 calculating	 their	 mean-squared-displacement	 (MSD)	
according	to	the	following	formula	(55):	
푀푆퐷푛∙∆푡=1푁−푛−1푗=1푁−푛−1푥푗∆푡+푛∆푡−푥푗∆푡2+푦푗∆푡+푛∆푡−푦푗∆푡2	 (S1)	
where	Δt	 is	 the	 time	 lag,	N	 is	 the	 total	number	of	 frames	of	 the	 trajectory,	n	 represents	 the	 time	
increment	 and	 x,y	 represent	 the	 2D	 particle	 position.	 Short-range	 diffusion	 coefficients	 were	
extracted	from	the	linear	fit	to	the	2nd-	4th	point	of	the	MSD	curve	using	the	following	equation:	
푀푆퐷=4퐷2−4푡+∆0	 	 	 	 	 (S2)	
where	D2-4	is	the	instantaneous	diffusion	coefficient	and	Δ0	is	the	MSD	offset	at	zero	time	increment.	
The	 smallest	 detectable	 diffusion	 coefficient	 was	 obtained	 after	 imaging	 immobilized	 QDs	 or	
Atto647N	 dyes	 on	 a	 coverslip	 using	 TIRFM	 at	 the	 same	 frame	 rate	 as	 in	 the	 corresponding	
experiments,	100Hz	and	10Hz	respectively.	Since	in	both	cases,	95%	of	the	immobile	QDs	displayed	
diffusion	 coefficients	 <1⋅10-3	 µm2/s,	 this	 value	was	 considered	 as	 the	 threshold	 for	 discriminating	
immobile	vs.	mobile	trajectories.	To	avoid	any	overestimation	of	the	immobile	fraction	due	to	non-
specific	interaction	of	QDs	or	Atto647N	dyes	with	the	coverslip,	only	trajectories	classified	as	mobile	
were	used	for	the	trajectory	analysis.	
Dual-color	 hCD1d	 trajectory	 analysis.	 Two-color	 QD	 tracking	 of	 labeled	 hCD1d	 (WT	 and	 TD)	
nanoclusters	 was	 performed	 at	 2nM	 concentrations	 to	 increase	 the	 probability	 of	 finding	
nanocluster	 interaction	 events.	 Two-dimensional	 fluorescence	 trajectories	 of	 spatially	 close	 QDs	
(red:	 iNKT-TCR-QD655	 and	 green:	 iNKT-TCR-QD585)	 were	 generated	 and	 the	 separation	 distance	
(interparticle	 distance)	 between	 QDs	 was	 determined	 from	 their	 dual-color	 pair	 trajectories	 by	
measuring	the	effective	distance	between	the	centroid	positions	of	the	diffusing	QDs	determined	by	
fitting	the	point-spread	function	of	the	microscope	with	a	Gaussian	curve.	Localization	accuracy	on	
the	 determination	 of	 the	 centroid	 position	 was	 20nm	 for	 both	 colors.	 The	 initial	 QDs	 separation	
distance	 considered	 was	 350nm	 and	 interparticle	 distances	 were	 calculated	 at	 every	 frame	 for	 a	
total	observation	time	of	1s	yielding	30	data	points	per	QD	pair.	Interparticle	distances	of	all	pairs	at	
every	 frame	 were	 collected	 into	 a	 histogram.	 Monte-Carlo	 simulations	 were	 performed	 to	
discriminate	 between	 random	 encounters	 of	 diffusing	 hCD1d	 nanoclusters	 or	 true	 enhanced	
interaction	 between	 hCD1d	 nanoclusters.	 100	 pairs	 of	 randomly	 diffusing	 nanoclusters	 were	
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simulated	 yielding	 3000	 simulated	 interparticle	 distances	 per	 simulated	 pair.	 The	 instantaneous	
diffusion	 coefficient	 for	 each	 experimental	 condition	 was	 used	 for	 simulating	 the	 dual-color	
trajectories.	
Dual-color	trajectory	analysis	of	iNKT-TCR-QD	labeled	hCD1d	on	Lifeact-GFP	labeled	actin.	A	single	
Lifeact-GFP	 fluorescence	 image	 was	 bandpass-filtered	 in	 the	 frequency	 domain	 using	 standard	
ImageJ	 image	 processing.	 Only	 QDs	 that	 visited	 both	 low-actin	 and	 high-actin	 regions	 during	 the	
time	course	of	an	experiment	(20s)	were	manually	tracked.	The	trajectories	were	then	divided	into	
10	points	segments	and	the	instantaneous	diffusion	coefficients	of	every	segment	were	calculated	as	
earlier	described.	The	segments	of	 the	trajectories	were	visually	classified	to	belong	to	either	 low-
actin	 or	 high-actin	 regions	 after	 thresholding	 (>75%)	 the	 normalized	 Lifeact-GFP	 fluorescence	
images.	
Generation	 of	 time-dependent	 membrane	 exploration	 maps.	 Time-dependent	 membrane	
exploration	 maps	 of	 iNKT-TCR-QD655	 labeled	 hCD1d	 (WT	 and	 TD)	 with	 respect	 to	 actin	 were	
obtained	as	described	in	Torreno-Pina	et	al.(37).	In	brief,	we	first	obtained	dual-color	TIRFM	images	
of	iNKT-TCR-QD655	and	Lifeact-GFP,	at	a	frame	rate	of	60Hz	and	for	a	total	observation	time	of	1200	
frames.	 The	 position	 of	 each	 single	QD	with	 20nm	 localization	 accuracy	was	 determined	 in	 every	
frame	 using	 a	 custom	 Matlab	 algorithm	 based	 on	 Serge	 et	 al.(54).	 The	 total	 number	 of	 QD	
localization	positions	in	all	the	frames	was	then	collapsed	in	one	single	image	and	overlaid	into	one	
single	Lifeact-GFP	fluorescence	image.	Cells	with	an	actin	cytoskeleton	that	did	not	change	over	the	
time	course	of	an	experiment	were	carefully	selected	for	generating	cartography	maps.		
Quantification	 of	 hCD1d	 localizations	 with	 respect	 to	 actin.	 Quantification	 of	 the	 data	 was	
performed	 by	 generating	 two	 concentric	 circles	 with	 different	 radii	 R1	 and	 R2	 (R1=225	 nm	 and	
R2=1035	nm)	and	having	each	time	a	given	localization	of	the	cartography	map	as	the	center	for	both	
circles	 (Fig.	 S4).	 The	 total	 number	 of	 localizations	 enclosed	 in	 each	 circle	was	 quantified;	with	N1	
being	the	total	number	of	 localizations	enclosed	by	circle	R1	and	N2	=	(#	of	 localizations	in	R2	–	N1).	
Moreover,	 the	 mean	 raw	 fluorescence	 intensity	 value	 of	 actin	 (A1	 and	 A2	 from	 R1	 and	 R2,	
respectively)	enclosed	by	each	radius	was	also	extracted	from	the	superimposition	of	the	circles	on	
top	of	the	actin	image.	This	procedure	was	repeated	by	positioning	the	center	of	the	two	concentric	
circles	 at	 each	 hCD1d	 localization	 value.	 The	 behavior	 of	WT-CD1d	 and	 TD-CD1d	molecules	 with	
respect	 to	 the	 actin	 cytoskeleton	 was	 extracted	 by	 plotting	 the	 relative	 fraction	 of	 hCD1d	
localizations	 (N1/N2)	 against	 (A1-A2)/A1=∆Actin.	 Only	 cells	 with	 a	 similar	 expression	 of	 lifeact-GFP	
were	selected	for	this	analysis.	
Sample	preparation	 for	STED	Nanoscopy.	To	avoid	any	potential	artifacts	due	to	CytoD	treatment	
on	membrane	morphology	that	could	affect	the	STED	imaging,	we	exclusively	focused	on	WT-hCD1d	
or	 TD-hCD1d	 transduced	 THP1	 cells.	WT-hCD1d	 or	 TD-hCD1d	 transduced	 THP1	 cells	 were	 pulsed	
overnight	with	 100ng/ml	α-GalCer	or	 400ng/ml	Gal-GalCer.	Alternatively,	WT-hCD1d	or	 TD-hCD1d	
transduced	THP1	cells	were	stimulated	with	10	µg/ml	R-848	for	30h.	Cells	were	then	stretched	on	
PLL-coated	 coverslips	 for	 30	 min	 at	 37ºC	 and	 with	 5%	 CO2.	 After	 cell	 fixation	 with	 2%	
paraformaldehyde,	 Fc-receptors	were	blocked	with	2%	human	 serum.	CDd1	molecules	on	 the	 cell	
membrane	were	labeled	with	5µg/ml	anti-CD1d42	Ab.	Fluorescent	secondary	antibody	labeling	was	
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performed	with	a	5µg/ml	goat	anti-mouse	Alexa	Fluor	488-labeled	antibody.	 Isotype	controls	were	
performed	in	order	to	test	the	specificity	of	the	labeling	procedure.	
Stimulated	 Emission	Depletion	 (STED)	Nanoscopy.	Confocal	 and	STED	 images	were	obtained	 in	 a	
sequential	 manner	 using	 a	 100x	 oil	 immersion	 objective	 (HCX	 PL	 APO	 100x/1.4	 Oil,	 Leica	
Microsystems,	 Germany)	 of	 a	 commercial	 CW-STED	 SP-7	 microscope	 (Leica	 Microsystems,	
Germany).	The	STED	laser	intensity	at	the	focal	plane	on	the	upper	cell	membrane	was	130mW,	and	
1024x1024	 pixels	 images	 were	 recorded	 at	 a	 scan	 speed	 of	 1400Hz.	 In	 these	 conditions,	 no	
significant	 fluorescence	 photobleaching	was	 observed.	 STED	 resolution	was	 85	 nm	 as	 determined	
from	 the	 full-width-at	 half-maximum	 of	 sparse	 labeled	 Abs	 on	 glass	 by	 fitting	 the	 point-spread	
function	of	the	STED	microscope	using	a	Lorentzian	curve.	
Analysis	 of	 the	 STED	 images.	 STED	 images	 were	 analyzed	 by	 means	 of	 a	 previously	 published	
algorithm	 based	 on	 Bayesian	 inference	 (36).	 The	 algorithm	 essentially	 relies	 on	 the	 detection	 of	
fluorescence	 features	 and	 their	 fitting	 as	 a	 sum	 of	 different	 point	 spread	 functions	 (PSFs)	 whose	
width	and	intensity	distribution	are	estimated	from	images	of	sparse	markers.	For	each	image,	the	
localization	positions	of	all	the	retrieved	PSFs	were	used	to	reconstruct	an	image	that	contains	the	
molecular	 localizations	 belonging	 to	 each	 fluorescent	 feature	 of	 the	 raw	 STED	 image.	 The	
performance	 of	 such	 analysis	 has	 been	 previously	 tested	 on	 simulated	 images	 in	 a	wide	 range	 of	
number	densities,	PSF	widths	and	signal-to-noise	ratio	(SNR)	(See	SI	text)	(36).	 In	our	experimental	
conditions	 (number	density=5-50	μm-2,	PSF	width=85	nm,	SNR=15-20	dB),	 the	algorithm	 is	 able	 to	
retrieve	a	large	percentage	(>80%)	of	particles	and	to	determine	their	location	with	high	localization	
accuracy	 (~20	nm).	Cluster	 size	and	number	of	hCD1d	molecules	per	 cluster	were	 then	 calculated	
from	the	reconstructed	images	using	the	pair-correlation	analysis	(36).	The	pair-correlation	function	
g(r)	was	calculated	on	reconstructed	images	obtained	by	convoluting	the	particle	localizations	with	
2D	Gaussian	functions	having	width	equal	to	the	 localization	accuracies.	Each	curve	represents	the	
average	of	at	least	30	pair	correlations	obtained	over	3x3	µm2	regions	of	interest.		
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Figure	Legends	
Figure	1.	The	actin	cytoskeleton	affects	the	mobility	of	hCD1d	molecules	on	the	surface	of	APCs.	
(A)	Schematic	illustration	of	the	labeling	procedure.	(Left)	α-GalCer	loaded	hCD1d	molecules	(blue)	
were	 labeled	 using	 a	 conjugate	 of	 an	 iNKT-TCR	 (light	 and	 dark	 green)	 and	 a	 QD	 (red).	 (Right)	
Unpulsed	hCD1d	molecules	were	 labeled	using	a	monovalent	anti-CD1d42	Ab	conjugated	to	a	QD.	
Not	to	scale.	(B)	Selected	TIRFM	image	of	the	ventral	side	of	a	α-GalCer	pulsed	THP-1	cell	displaying	
individual	 iNKT-TCR-QD-labeled	 hCD1d	molecules	 (red)	 on	 the	 cell	 membrane.	 Representative	 2D	
trajectories	(white)	are	overlaid	on	the	raw	image	(frame	rate=100	Hz).	(C)	Distributions	of	the	D2-4	
values	of	α-GalCer	loaded	hCD1d	labeled	with	the	iNKT-TCR-QD	conjugate	or	with	Fab9b-Atto647N.	
(D-F)	 Distributions	 of	 the	 D2-4	 values	 for	α-GalCer-pulsed	 (D),	 unpulsed	 (E)	 and	Gal-GalCer	 loaded	
hCD1d	 (F)	THP-1	cells	 treated	with	10	µM	CytoD	or	expressing	TD-hCD1d	mutant	molecules.	Note	
that	the	comparisons	of	D2-4	values	are	always	made	with	respect	to	the	basal	situation	(DMSO)	and	
specifically	for	each	lipid-loaded	condition,	since	the	basal	diffusion	of	hCD1d	depends	on	the	lipid.	
Data	are	representative	from	typically	200	trajectories	per	condition	(90	trajectories	 in	the	case	of	
hCD1d	labeled	with	Fab9b-Atto647N)	from	at	least	25	cells	over	8	different	experiments.	*p<0.0001,	
ns:	not	significant	(p>0.05)	(one-way	ANOVA	test).		
Figure	2.	hCD1d	molecules	form	nanoclusters	on	the	surface	of	APCs	whose	properties	depend	on	
actin	cytoskeleton	interactions.	(A)	STED	images	of	α-GalCer	pulsed	(upper	row),	Gal-GalCer	pulsed	
(middle	row)	and	unpulsed	 (lower	row)	THP-1	cells	 transfected	with	WT-hCD1d	(left)	or	TD-hCD1d	
(right)	mutant.	 Cells	were	 stretched	 onto	 PLL-coated	 coverslips	 and	 labeled	with	 anti-CD1d42	Ab.	
(B,E,H)	Cluster	 size	distribution,	 (C,F,I)	 distribution	of	 the	number	of	 hCD1d	molecules	 per	 cluster	
and	(D,G,J)	scatterplots	of	number	of	hCD1d	molecules	per	cluster	vs.	cluster	area	corresponding	to	
the	 quantification	 of	 the	 STED	 images.	 STED	 nanoscopy	 data	 are	 representative	 from	 at	 least	 43	
different	 images	per	condition,	of	3x3	µm	in	size	 from	at	 least	2	different	experiments.	Horizontal	
bars	correspond	to	median	values.	*p<0.01	and	**p<0.0001	(one-way	ANOVA	test).	
Figure	3.	The	actin	cytoskeleton	regulates	dynamic	interactions	between	α -GalCer	loaded	hCD1d	
nanoclusters.	 	 (A)	 Schematic	 illustration	 of	 two	α-GalCer	 loaded	 hCD1d	molecules	 (blue)	 labeled	
with	 two	 different	 iNKT-TCR-QD-conjugates	 (green	 and	 red)	 at	 equimolar	 concentrations.	 Not	 to	
scale.	 (B)	 Magnified	 dual-color	 TIRFM	 images	 (1.9	 µm	 in	 size)	 displaying	 two	 diffusing	 hCD1d	
nanoclusters	over	 time,	 for	 the	control	case	 (left	column),	CytoD	treated	samples	 (middle	column)	
and	the	TD-hCD1d	mutant	(right	column).	White	arrows	indicate	the	starting	time	of	the	interaction.	
(C)	Representative	dual-color	 trajectories	of	 two	different	hCD1d	nanoclusters	 reconnected	over	a	
total	 observation	 time	of	1s	 (frame	 rate:	 30	Hz).	 (D)	 Separation	distances	of	 two	α-GalCer	 loaded	
hCD1d	nanoclusters	over	time	for	untreated	WT–hCD1d	(green),	CytoD	treated	WT-hCD1d	(red)	and	
the	TD-hCD1d	mutant	(blue).	(E)	Distributions	of	the	interparticle	distances	from	experimental	data	
(color	 dots)	 together	 with	 Monte	 Carlo	 simulations	 of	 random	 encounters	 (gray	 dots).	 Data	 are	
representative	of	at	least	20	different	trajectories	on	9	different	cells	per	condition	over	6	different	
experiments.	*p<0.05	and	**p<0.0001	(one-way	ANOVA	test).	
Figure	4.	The	actin	cytoskeleton	actively	arrests	diffusing	α -GalCer	loaded	hCD1d	nanoclusters	on	
the	 cell	membrane.	 (A)	 Snapshot	of	a	dual-color	TIRFM	movie	displaying	 lifeact-GFP	 labeled	actin	
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(green)	 and	α-GalCer	 loaded	 hCD1d	 nanoclusters	 (red)	 labeled	 with	 the	 iNKT-TCR-QD	 conjugate.	
Scale	bar:	2	µm.	(B,C)	Representative	magnified	TIRFM	images	at	two	different	time	sequences	with	
an	 example	 of	 a	 2D	 trajectory	 of	α-GalCer	 loaded	 hCD1d	 diffusing	 inside	 (black	 line)	 and	 outside	
(white	line)	actin-rich	regions,	with	the	diffusing	particle	outlined	with	a	red-dashed	circle.	In	panel	
(B)	hCD1d	is	inside	actin,	while	(C)	shows	the	time	sequence	when	hCD1d	is	outside	actin.	Scale	bar:	
500	nm.	(D)	Distributions	of	the	D2-4	values	for	α-GalCer	loaded	WT-hCD1d	and	α-GalCer	loaded	TD-
hCD1d	 nanoclusters	 inside	 and	 outside	 high-actin	 regions.	 The	 D2-4	 values	 reported	 here	 are	
somewhat	different	as	to	the	median	values	reported	in	the	corresponding	Fig.	1,	as	a	pre-selected	
number	 of	 trajectories	 that	 diffused	 outside	 and	 inside	 actin-rich	 regions	 were	 chosen	 for	 this	
analysis.	 (E,F)	Cumulated	cartography	maps	containing	8000	 localizations	over	a	 recording	 time	of	
20s	from	α-GalCer	loaded	WT-hCD1d	(E)	and	TD-hCD1d	(F)	overlaid	onto	a	lifeact-GFP	TIRFM	image.	
The	 white	 dots	 correspond	 to	 the	 different	 spatial	 positions	 explored	 by	 hCD1d	 during	 the	
observation	 time.	 The	 pseudo-colored	 image	 corresponds	 to	 the	 actin	 intensity,	 going	 from	 blue	
(actin-low)	to	red	(actin-rich).	The	black	filled	arrows	point	to	hCD1d	diffusion	on	actin-poor	regions,	
whereas	empty-black	arrows	point	to	hCD1d	diffusing	close	to	actin-rich	regions.	Scale	bar:	1	µm	(G)	
Fractional	 occurrence	 of	 hCD1d	 localization	 positions	 vs.	 changes	 in	 actin	 intensity,	 ∆Actin	 for	α-
GalCer	 loaded	 WT-hCD1d	 (black)	 and	 α-GalCer	 loaded	 TD-hCD1d	 (red).	 Data	 were	 fitted	 with	 a	
straight	line	and	the	slope	was	obtained.	SPT	data	from	at	least	87	trajectories	on	30	different	cells	
over	5	different	experiments.	Cartography	maps	data	contain	at	least	8000	localizations.	Analysis	has	
been	performed	on	6	different	cells	and	3	different	experiments	per	condition.	*p<0.0001	(Student’s	
t-test).	
Figure	 5.	 Perturbation	 of	 the	 actin	 cytoskeleton	 on	 α -GalCer	 pulsed	 APCs	 enhances	 iNKT	 cell	
activation.	(A,B)	 IFN-γ	production	upon	 iNKT	cell	activation	by	(A)	hCD1d	transduced	THP1	cells	or	
(B)	 immature	 dendritic	 cells	 (imDCs),	 pulsed	 with	 the	 given	 α-GalCer	 concentrations	 overnight	
before	 treatment	with	Cyto	D.	 (C)	 Expression	 levels	 of	 hCD1d	as	measured	by	 FACS	after	 treating	
THP1	cells	with	CytoD	 (10	µM,	1h).	 (D)	 IFN-γ	production	upon	 iNKT	cell	activation	by	hCD1d	THP1	
cells	stimulated	with	10	µg/ml	of	TLR	7/8	ligand	R848	for	30h	before	CytoD	treatment.	The	unpulsed	
column	refers	to	no	lipid.	(•)	Intensity	value	below	the	detection	limit.	Data	are	representative	of	3	
different	experiments.	*p<0.05,	ns:	not	significant	(p>0.05)	(Student’s	t-test).  	
Figure	6.	The	actin	cytoskeleton	regulates	hDC1d	nanoclustering	under	 inflammatory	conditions.	
(A)	 STED	 images	of	unpulsed	WT-hCD1d	 (upper	 row),	R848-WT-hCD1d	 (middle	 row)	and	R848-TD-
hCD1d	 (lower	 row)	 on	 the	 dorsal	 cell	 membrane	 of	 THP-1	 cells	 stretched	 on	 PLL-coated	 glass	
coverslips.	(B,E)	Distributions	of	cluster	size;	(C,F)	distribution	of	the	number	of	hCD1d	molecules	per	
cluster;	 and	 (D,G)	 scatterplots	 of	 the	 number	 of	 hCD1d	 molecules	 per	 cluster	 vs.	 cluster	 area	
corresponding	to	the	quantification	of	the	STED	images.	STED	nanoscopy	analysis	data	from	at	least	
30	 different	 images	 of	 3x3	 µm	 in	 size,	 from	 at	 least	 2	 different	 experiments.	 Horizontal	 bars	
correspond	to	median	values.	*p<0.0001	(one-way	ANOVA	test).	
Figure	7.	The	actin	cytoskeleton	controls	CD1d	nanoclustering	on	the	surface	of	APCs,	fine-tuning	
iNKT	activation.	(A)	Small	basal	nanoclusters	of	stimulating-lipid	loaded-CD1d	molecules	are	present	
on	 the	 cell	 membrane	 of	 APCs.	 Barriers	 and/or	 obstacles	 by	 the	 actin	 cytoskeleton	 keep	 CD1d	
nanoclusters	 away	 from	 each	 other	 limiting	 their	 aggregation	 state,	 regulating	 in	 turn	 iNKT	 cell	
	 25	
activation	 even	 under	 inflammatory	 conditions	 ("iNKT	 cell	 autoreactivity").	 (B)	 Re-arrangement	 of	
the	 actin	 cytoskeleton	 (achieved	 in	 our	 case	 by	 the	 use	 of	 CytoD	 treatment)	 increases	 the	
encountering	 rate	between	CD1d-1d	nanoclusters,	 resulting	 in	 the	 formation	of	 larger	 lipid-loaded	
CD1d	nanoclusters	and	increased	iNKT	cell	activation.	
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